Hit enter to search or ESC to close
HOME
IDIBELL
Foreword
Governing bodies
People
Financial information
RESEARCH
Highlights
Research groups
Core facilities
INNOVATION
SOCIETY
Financial report
Summary
Full report
Income
Competitive funding
9.925.346,97 €
Non-competitive funding
11.725.148,61 €
Generalitat of Catalonia, Board
5.160.028,93 €
Internal billing
528.244,48 €
Indirect costs
Competitive funding
1.292.638,03 €
Non-competitive funding
2.860.119,82 €
TOTAL
27.338.768,99 €
TOTAL
4.152.757,85 €
Indirect costs
DOWNLOAD BALANCE SHEET
DOWNLOAD 2019 INCOME STATEMENT
HOME
IDIBELL
Foreword
Governing bodies
People
Financial information
RESEARCH
Highlights
Research groups
Core facilities
INNOVATION
SOCIETY
CANCER
Molecular mechanisms and experimental therapy in oncology – Oncobell
Tumour angiogenesis
Cancer virotherapy and immunotherapy
Colorectal cancer
Chemoresistance and predective factors to tumor response and stromal microenvirontment
Cell death regulation
Apoptosis and cancer
TGF-beta and cancer
Hematopoyetic and lymphoid tumors
Sarcoma
Radiobiology and cancer
Hereditary cancer
Breast cancer
Metabolism and cancer
Neuro-oncology
Gynecologic cancer
Resistance and progression mechanisms in prostate cancer
Head and neck disesases
Clinical research in solid tumours
Cancer epigenetics and biology
Cancer epigenetics
Chromatin biology
Genes and cancer
Chromatin and disease
Cell cycle
Ageing and cancer
Genomic imprint an cancer
Transformation and metastasis
Cellular differentiation
Regulatory RNA and chromatin
Epidemiology, public health, cancer prevention and palliative care
Cancer control and prevention
Infections and cancer
Palliative care
Nutrition and cancer
NEUROSCIENCES
Cognition and brain plasticity
Neuropathology
Cellular and molecular neurobiology
Neurometabolic diseases
Neuropharmacology and pain
Psychiatry and mental health
Cellular and molecular basis of sensory disorders
Neurologic Diseases and Neurogenetics
Perisurgical physiopathology and pain
Stem cells and Neurodegenerative diseases
TRANSLATIONAL MEDICINE
Infectious disease and transplantation
Innate immunity and pathology of the critical patient
Nephrology and renal transplantation
Infections of the respiratory tract and in immunocompromised patients
Epidemiology of bacterial infections. Investigation of the pathogenesis and molecular basis of antimicrobial resistance
Difficult to treat infections and antimicrobians use
Diabetes and metabolism
Diabetes, nutrition and endocrinological diseases
Nutrition, metabolism and gene therapy
Cell signalling and bone biology
Cardiovascular, respiratory and systemic diseases and cellular aging
Pneumology
Synovial inflammation and bone metabolism
Systemic diseases and bone metabolism
Cardiovascular disease
Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention
Image diagnosis and nuclear medicine
Hepato-biliary-pancreatic pathology
Digestive tract pathology
Clinical prevention
Odontological and maxillofacial pathology and therapeutics
Pharmacotherapy, pharmacogenetics and pharmaceutical technology
Nursing
Oral health and masticatory system
Functional and motor gastrointestinal disorders
Genes, disease and therapy
Human molecular genetics
Physiology and pathology of the functional relationship between glia and neurons
Modeling human diseases in C. elegans
Immune-inflammatory processes and gene therapeutics
IDIBELL ANNUAL REPORT 2019